Mr. Chair and honourable colleagues, as Conservatives, we've always placed the health and safety of all Canadians at the forefront through practical, accountable and results-driven policies that respect taxpayers and deliver measurable outcomes.
We support this motion under Standing Order 108 for an urgent study on the rising rates of HIV infections in Canada, with a particular focus on the public health emergency declared by the Province of Manitoba.
After years of federal Liberal management of health programs and coordination efforts, we are witnessing troubling localized surges that demand serious scrutiny, transparency and concrete recommendations to protect vulnerable communities and ensure that every dollar spent produces real results for families across the country.
On May 7, 2026, Manitoba took the serious step of declaring a public health emergency because new HIV diagnoses had climbed dramatically from just 90 cases in 2019 to 328 in 2025, representing more than a tripling of cases in six years. In 2024, the province reported a rate of 19.5 cases per 100,000 people, which is over three and a half times the national average of 5.5 per 100,000. Early data for 2026 already shows around 120 new cases in the first quarter alone, and projections suggest that without effective intervention, the province could face as many as 1,080 new cases by 2028.
This crisis is compounded by rising syphilis infections, co-infections and heartbreaking perinatal transmissions, with one infant born with HIV in 2024 and another in 2025. These are preventable tragedies that underscore the urgency of our work.
Nationally, Canada had 2,288 HIV diagnoses in 2024, reflecting a modest 3.3% decrease from the previous year, yet the national rate stands at 5.5 diagnoses per 100,000 people. While some provinces show stability or slight improvements, the prairie hot spots are Manitoba and Saskatchewan, with rates of about 18.6 per 100,000 people in the latter.
The overall picture is the wrong direction. Conservatives have consistently championed evidence-based policy-making and proposed studies to give us the chance to take a hard look at questions about why, despite substantial federal investments over many years, certain regions and populations continue to experience escalating challenges. We must examine the data thoroughly, identify the gaps in prevention and care and recommend practical solutions that prioritize outcomes over announcements.
This study may pay close attention to the disproportionate impacts on specific communities as outlined in the motion. Indigenous people are tragically overrepresented in these new diagnoses, especially in Manitoba and Saskatchewan. Historical factors, combined with ongoing realities such as remote geography, housing instability, barriers to culturally safe care and intersecting social determinants, have contributed to these disparities.
Conservatives believe in empowering indigenous communities with practical tools, supporting self-determination, ensuring sufficient use of funding through organizations like the first nations and Inuit health branch and delivering services that combine cultural respect and modern medical excellence. We need to hear directly from indigenous health organizations about what is working on the ground and where federal supports can be made more responsive and less bureaucratic.
Women in Manitoba are bearing a particularly heavy burden, accounting for more than 50% of the new cases in recent years, compared to roughly 32% nationally. Many of these women are under 40, and the intersections with heterosexual transmission, injection drug sites, caregiving responsibilities, economic pressures and the experience of violence often delay testing and treatment.
Conservatives support family-centred approaches that strengthen prenatal screening, ensure rapid linkage to care and provide holistic support so that mothers and children can thrive. Even a single perinatal transmission is one too many, and our study must explore how federal prevention tools can better reach these women in real-world settings.
In the 2SLGBTQI+ communities, stigma continues to create barriers to testing and consistent care. Proven strategies such as regular testing, education on risk reduction and access to tools like PrEP have shown success in the past when implemented with clarity and personal responsibility at their core.
We must build on those models while ensuring that campaigns reach beyond urban centres into rural and northern realities, where needs differ. Rural, northern and remote communities face their own distinct challenges: long travel distances, a shortage of providers, limited pharmacy access and difficulty with follow-up care. Regions like Prairie Mountain Health and Northern Health Region in Manitoba illustrate these issues vividly.
Conservatives understand rural Canada intimately, and we believe federal programs should cut unnecessary red tape, support effective telemedicine and enable flexible delivery that respects provincial and local innovation rather than imposing one-size-fits-all Ottawa solutions.
Individuals experiencing homelessness, mental health challenges and substance use disorders find themselves caught in a dangerous syndemic. Unstable housing increases exposure through survival, sex work or shared equipment; mental health struggles affect treatment adherence; and injection drug use, particularly involving—I'm going to say this slowly so the interpreters get it—methamphetamine and fentanyl, drive a significant portion of transmission in Manitoba, sometimes linked to up to 70% of the cases.
Conservatives advocate a balanced, compassionate approach to harm reduction. Needle exchange programs and supervised consumption sites can play a role in immediate risk. However, they must be paired with strong pathways to treatment, recovery, housing and economic opportunities. Models that focus solely on enabling use without emphasizing getting people healthy have not reversed broader addictions and overdose crises in many cities. This study should examine integrated solutions that break cycles and then manage them indefinitely.
Turning to the federal role, Canadians rightly expect transparency and accountability for how their tax dollars are spent on health initiatives. The federal initiative to address HIV/AIDS and broader sexually transmitted and blood-borne infection efforts channel tens of millions annually. With community grants, surveillance, research and awareness programs led by the Public Health Agency of Canada in coordination with other departments, we must scrutinize whether these investments are yielding the desired reduction in infections, particularly in hot spot regions.
Prevention strategies include PrEP scale-up, education campaigns and condom distribution, each effective among high-need populations. Do current awareness efforts truly connect with indigenous audiences, rural residents and those facing substance use in culturally relevant and direct ways? Testing and treatment access, including rapid point-of-care options and progress towards the 95-95-95 targets of diagnosis, treatment and viral suppression, deserve closer examination because gaps remain stubborn in remote and marginalized communities.
Harm reduction initiatives warrant balanced review. While clean needle programs save lives in the short term, Conservatives stress that they cannot stand alone without robust emphasis on recovery and treatment on demand.
There is a risk of normalizing addiction amid the ongoing fentanyl and methamphetamine crises, which fuel injection-related HIV transmissions. Public awareness efforts must have clear, evidence-based messaging rather than vague approaches, and they should be tailored to indigenous languages and formats that resonate with northern and 2SLGBTQI+ audiences. Intergovernmental coordination among the Public Health Agency of Canada, provincial authorities like Manitoba Health, indigenous organizations and frontline providers is critical.
Delays in data sharing or mismatches in funding can cost precious weeks or months in outbreak responses. This study should explore how federal levers can support provincial innovations without duplication or excessive bureaucracy.
Witness testimony will be invaluable. Officials from the Public Health Agency of Canada can detail national surveillance systems and response times to Manitoba's alert. The Minister of Health should address accountability for outcomes and any coordination bottlenecks. Representatives from Manitoba Health can outline specific federal supports requested versus those received and how emergency measures are unfolding on the ground.
Indigenous health organizations will bring perspective on culturally safe models and funding efficiencies. Frontline community organizations and medical experts can speak to daily barriers and clinical innovations, while individuals with lived experience can offer powerful insight into what actually turns lives around.
Whether through consistent treatment adherence, stable housing or recovery-focused programs, at least two dedicated meetings provide a foundation, but we should be prepared to dig deeper into the program, evaluations and return on investment analysis. Past reviews have not led to gains in awareness and knowledge exchange but to weaker performance on concrete infection reduction metrics, and that pattern must change.
The proposed timeline matters deeply. A reporting deadline of July 22, 2026, combined with the flexibility for summer meetings if the House, when it rises, provides authority for the chair to schedule sessions, plus the ability to seek House permission to table the report afterwards, will demonstrate that the committee takes the active public health emergency seriously.
Manitoba's situation cannot wait until fall. Conservatives have always pushed for the efficient use of parliamentary time that puts people ahead of procedural delays. A focused report emerging from this work can deliver actionable recommendations on immediate federal levers, such as improved data protocols, targeted funding pilots for rural infrastructure, reduced administrative hurdles and balanced harm reduction paired with recovery metrics.
Let us consider the broader context and lessons from history. Canada has made meaningful progress against HIV over decades through scientific advances, community dedication and focused policy. Previous Conservative governments emphasized strong surveillance, targeted funding and measurable accountability. In recent years, despite continued or increased spending in some areas, we have seen localized surges that reveal gaps where social determinants, chronic housing shortages, the addiction epidemic, family breakdown and the economic pressures intersect with health delivery.
We must learn from jurisdictions and models that successfully balance biomedical tools with behaviour, prevention, personal models, responsibility and the recovery pathway. Strong border controls against importing illicit drugs, support for law enforcement tackling fentanyl networks and economic policies that lift people out of poverty all form part of the comprehensive national strategy.
To expand on Manitoba's emergency in great depth, the tripling of cases from 90 in 2019 to 328 in 2025, the fact that more than half are among women under 40, the regional concentration in prairie, mountain and northern health areas and the syphilis co-infection surge all point to a syndemic that requires coordinated action.
We should ask witnesses what precise federal resources Manitoba requested and whether delivery was timely. How can successful provincial testing expansion, PrEP, and outreach and community initiatives be amplified nationally while fully respecting jurisdictional roles? On indigenous health, the overrepresentation demands attention to self-determination, efficient funding flows and integration of traditional knowledge with evidence-based medicine.
Flexible block funding models that let communities set priorities could yield better results than top-down programs. Rural and northern access issues deserve extended discussion. Transportation barriers, pharmacy shortages in remote areas and specialist wait times are not abstract. They prevent people from staying on treatment and achieving viral suppression.
Conservatives favour federal transfers that empower provinces and territories to innovate with mobile clinics, provider incentives, and technology solutions tailored to local needs. The substance use dimension links directly to the wider opioid and stimulant crisis. Data shows that injection drug use is driving many Manitoba cases, and that reinforces the need for oversight and a safer supply approach and to make this a clear priority.
Manitoba cases on the treatment-first model.... Comparing outcomes between recovery-focused programs and harm reduction-only approaches will provide valuable evidence for recommendations.
Federal funding deserves rigorous value-for-money scrutiny. Tens of millions are flowing annually through the federal initiative, yet outcomes in the prairie provinces lag. We must trace multi-year allocations, examine the history of underspending or inefficiencies, and calculate the true return on investment. Lifetime costs of antiviral treatments for one person run into hundreds of thousands of dollars, making effective prevention not only compassionate but financially responsible.
International and historical comparisons can inform our work. Canada's progress towards UNAIDS targets in hot spots versus other countries that have achieved sharper declines through combined strategies, and lessons from the 1980s and 1990s responses, which paired medical advances with clear behavioural messaging, remain relevant today.
In preparing for witness sessions—